The FDA has scheduled an Oct. 15 meeting of its advisory committee to discuss whether to grant authorization for a booster dose of the J&J vaccine.
Related Articles
-
‘It’s just snowballing’: In some states, health care workers wait months for licenses
Last September, Michelle Thomas thought she was about to start a new job as a therapist serving a clinic...
-
CDC recommends RSV vaccine given during pregnancy to protect babies
Pregnant people should get an RSV vaccine at 32 to 36 weeks’ gestation in order to protect their newborns...
-
Illnesses linked to McDonald’s E. coli outbreak rise to 75, CDC says
At least 75 people have gotten sick after eating McDonald’s Quarter Pounders linked to a deadly E. coli strain,...
-
Henrietta Lacks’ family settles with biotech company over cancer cells
IE 11 is not supported. For an optimal experience visit our site on another browser. New survey finds 911...
-
FDA recommends including omicron subvariants BA.4 and BA.5 in fall Covid boosters
The next round of Covid booster shots should be modified to target the extremely contagious omicron subvariants BA.4 and...
-
Poster’s Macron-Hitler comparison draws legal trouble as vaccine mandates stir French anger
French President Emmanuel Macron has spent the past few weeks fighting back against critics of his tough coronavirus measures....
-
Gym closures and pandemic stress are taking a toll on mental health
IE 11 is not supported. For an optimal experience visit our site on another browser. 04:15 Share this –...
-
In severe bird flu cases, the virus can mutate as it lingers in the body
A 13-year-old girl in British Columbia who was hospitalized with bird flu for several weeks late last year harbored...
Recent Comments